← Browse by Condition
Medical Condition

high grade ta t1 papillary disease bladder cancer

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT07283835 Phase 2
Recruiting

Study of Cretostimogene Given in Patients With Non-Muscle Invasive Bladder Cancer ,Unresponsive to Bacillus-Calmette-Guerin

Enrollment
16 pts
Location
China
Sponsor
Lepu Biopharma Co., Ltd.
View Trial →